Evidence map›Paper›PMID 22180182›Full record

ArticleJournal of genetic counseling2012

"It's not like judgment day": public understanding of and reactions to personalized genomic risk information.

Erynn S Gordon, Georgia Griffin, Lisa Wawak, Hauchie Pang, Sarah E Gollust, Barbara A Bernhardt

Abstract read
In one paragraph

Article in Journal of genetic counseling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Perspectives of diverse Spanish- and English-speaking patients on the clinical use of polygenic risk scores.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cancer communication research in the era of genomics and precision medicine: a scoping review.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Erynn S GordonCoriell Institute for Medical Research, Camden, NJ, USA.
Georgia Griffin
Lisa Wawak
Hauchie Pang
Sarah E Gollust
Barbara A Bernhardt
Coriell Institute For Medical Research · USApplied Genetic Technologies (United States) · USGenetic Technologies (Australia) · AUMinnesota Department of Health · USUniversity of Pennsylvania · US

Funding

Penn Center for ELSI Research in Emerging Genetic Technologies in Health CareP50HG004487 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI PYERITZ, REED E · 2007 to 2012
$6.2M
Assessing Attitudes and Experiences of Early Adopters of Personalized GenomicsRC1HG005369 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI BERNHARDT, BARBARA A. · 2009 to 2010
$647k
NHGRI NIH HHS 1-P50HG004487-01NHGRI NIH HHS 1RC1HG005369-01NHGRI NIH HHS P50 HG004487NHGRI NIH HHS RC1 HG005369
6 · The paper itself

Abstract

The value of genomic risk assessment depends upon patients making appropriate behavioral changes in response to increased risk leading to disease prevention and early detection. To date, few studies have investigated consumers' response to personalized genomic disease risk information. To address this gap, we conducted semi-structured interviews with 60 adults participating in the Coriell Personalized Medicine Collaborative. The interviews took place after receiving results providing genomic and other risk information for up to eight common complex diseases. We found that participants were most likely to recall results which conferred an increased risk or those of particular personal interest. Participants understood the multi-factorial nature of common complex disease, and generally did not have negative emotional responses or overly deterministic perceptions of their results. Although most participants expressed a desire to use results to improve their health, a minority had actually taken action (behavior change or shared results with their doctor) at the time of the interview. These results suggest that participants have a reasonable understanding of genomic risk information and that provision of genomic risk information may motivate behavior change in some individuals; however additional work is needed to better understand the lack of change seen in the majority of participants.

Indexed as

GenomicsPrecision MedicineFemaleHumansMaleRisk Assessment

Identifiers

PMID22180182
PMCPMC3348376
OpenAlexW2170357314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.